OraSure (OSUR) Could Rise on New Government Data
Tweet
Share
E-mail
Get Alerts OSUR Hot Sheet
Join SI Premium – FREE
OraSure (Nasdaq: OSUR) could see more upside in the coming months
The company, which manufactures the OraQuick In-Home HIV Test, is getting a little boost from a new government health report which states that half of young people infected with HIV aren't even aware of it.
The U.S. Centers for Disease Control and Prevention said 26 percent of all new HIV infections come from an age group spanning 13 to 24 years old. Data also points out that 1,000 young people become infected per month and the disease costs $400,000 or so to treat over a lifetime.
The CDC also noted that only 13 percent of high school students have ever been tested for HIV.
On the news today (which was released late Tuesday), shares of OraSure are about 1.7 percent higher.
The company, which manufactures the OraQuick In-Home HIV Test, is getting a little boost from a new government health report which states that half of young people infected with HIV aren't even aware of it.
The U.S. Centers for Disease Control and Prevention said 26 percent of all new HIV infections come from an age group spanning 13 to 24 years old. Data also points out that 1,000 young people become infected per month and the disease costs $400,000 or so to treat over a lifetime.
The CDC also noted that only 13 percent of high school students have ever been tested for HIV.
On the news today (which was released late Tuesday), shares of OraSure are about 1.7 percent higher.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage
- JPMorgan tells investors to buy this mega-cap AI stock on weakness
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
Create E-mail Alert Related Categories
Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
